PATH EX
PATH EX has developed a proprietary technology to selectively separate and capture bacteria and toxins from human blood, for the treatment of sepsis. Sepsis, a life-threatening condition that commonly presents itself as a blood-borne infection, is the number one cause of death in the ICU and is the largest cost on their healthcare system. PATH EX is taking a novel approach by capturing and removing intact bacteria from the blood rather than trying to kill the infection with broad spectrum antibiotics. The PATH EX device is effective regardless of bacteria type or drug resistance. The PATH EX technology has the potential to reduce diagnostic times, treatment costs, readmission rates, and sepsis related deaths.
Domain
pathex.co
Country
United StatesIndustry
Health DiagnosticsEmployees
1-10
Last Funding
$5.0M
Founded
2015
Tech Stack (15 technologies)
Frequently Asked Questions
What technologies does PATH EX use?+
PATH EX uses 15 technologies including Google Analytics, Google Tag Manager, WordPress.
What industry is PATH EX in?+
PATH EX operates in the Health Diagnostics industry.
Where is PATH EX based?+
PATH EX is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026